Frontlight ResearchEarly access
Active, not recruitingPhase 3
The Use of Atropine 0.01% in the Prevention and Control of Myopia (ATOM3)
Key facts
- Who runs it
- Singapore National Eye Centre
- Where
- Singapore1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- Phase
- Phase 3
- People taking part
- 300 people enrolled
- Started
- 21 Apr 2017
- Ended
- 31 Dec 2025
- Type of study
- Interventional, 4 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Atropine sulfate 0.01%
- Placebo
- Record updated
- 18 May 2025
Who can take part
- Age
- 5 years to 9 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- One parent with myopia (<-3D in at least one eye)
- SE +1.00D to -1.50D
- Astigmatism < = 1.50D
- Distance vision logMAR 0.2 or better in both eyes
- Intraocular pressure of not greater than 21 mmHg
- No allergy to atropine, cyclopentolate, proparacaine and benzalkonium chloride
Who cannot take part
- Previous use of atropine or pirenzepine
- Any eye or systemic disease that affect vision or refractive error
- Conditions where topical atropine contraindicated
- Known past/current amblyopia or strabismus
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Study of low dose atropine in preventing the onset and progression of myopia in high risk children with pre-myopia or low-myopia.
The 4 groups in the trial
- Premyopia atropineExisting treatment, for comparison
On Atropine 0.01%
Treatment: Atropine sulfate 0.01%
- Premyopia placeboPlacebo, for comparison
On placebo
Treatment: Placebo
- Low myopia atropineExisting treatment, for comparison
On Atropine 0.01% daily or every other day
Treatment: Atropine sulfate 0.01%
- Low myopia placeboPlacebo, for comparison
On placebo
Treatment: Placebo
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 18 May 2025